logo
logo
Sign in

Parkinson's Disease Treatment Market Report With Major Players Outlook and Regional Analysis by 2025

avatar
Nasir Jones

According to IMARC Group’s latest report, titled “Parkinson's Disease Treatment Market Growth, Trends, Share, Size, Demand, Opportunity and Forecast 2020-2025”, the global parkinson's disease treatment market grew at a CAGR of around 6% during 2014-2019. Looking forward, IMARC Group expects the global market to continue its moderate growth during the next five years.

Parkinson’s disease refers to a progressive nervous system disorder that affects movements in an individual. It is characterized by the degeneration of motor neurons in the brain that leads to the development of rigidity, tremors, motor impairment, depression and dementia. Healthcare professionals are widely utilizing medications, supportive therapies and surgical procedures to manage the symptoms of the disease in an efficient manner and offer comfort to the patient during a seizure. Some of the most commonly prescribed medications include dopamine agonists, anticholinergics and carbidopa-levodopa medicines.

The parkinson's disease treatment market is primarily driven by the steadily increasing number of patients suffering from Parkinson’s disease on the global level. Along with this, a considerable rise in the geriatric population that is more prone to develop neurodegenerative ailments is expected to provide a thrust to the market growth. Moreover, continual developments in gene therapy, neurostimulation tools, and neural transplantation procedures are anticipated to create a positive outlook for the market. Some of the other factors contributing to the market growth include rising awareness regarding efficient treatment options and significant improvements in the healthcare infrastructure.

Get a PDF sample of this report for more detailed market insights: https://www.imarcgroup.com/parkinsons-disease-treatment-market/requestsample

Parkinson's Disease Treatment Market 2020-2025 Competitive Analysis and Segmentation:

Competitive Landscape:                                                                    

The competitive landscape of the parkinson's disease treatment market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:                                                                       

  • AbbVie Inc.
  • Acadia Pharmaceuticals Inc.
  • Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline Plc
  • H. Lundbeck A/S
  • Merck & Co. Inc.
  • Mylan N.V.
  • Novartis AG
  • Orion Corporation
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries
  • Wockhardt Ltd.

The report has segmented the global parkinson's disease treatment market on the basis of region, drug class, administration and distribution channel.

Breakup by Drug Class:

  • Carbidopa/Levodopa
  • Dopamine Receptor Agonists
  • MAO Inhibitors
  • COMT Inhibitors
  • Anticholinergics
  • Others

Breakup by Route of Administration:

  • Oral
  • Transdermal
  • Subcutaneous
  • Intestinal Infusion
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Breakup by Region:                                              

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Explore full report with table of contents: https://www.imarcgroup.com/parkinsons-disease-treatment-market

Key highlights of the report:                     

  • Market Performance (2014-2019)
  • Market Outlook (2020- 2025)
  • Market Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Browse Related Reports:

Hypoactive Sexual Desire Disorder Treatment Market

Polycystic Ovarian Syndrome Treatment Market Analysis

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal

collect
0
avatar
Nasir Jones
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more